{"listing":{"listing_type":"product","name":"Porustobart","slug":"porustobart","tagline":"Engineered CTLA-4 antibody for neoadjuvant immuno-oncology","description":"Porustobart is Solstice Oncology's investigational second-generation heavy-chain-only CTLA-4 antibody being studied in combination with anti–PD-1 therapy in the neoadjuvant setting, starting with MSS stage III colon cancer.","url":"https://www.solsticeoncology.com/","is_stealth":false,"normalized_domain":"solsticeoncology.com","normalized_url_key":"solsticeoncology.com","parent_slug":"solstice-oncology","parent":{"slug":"solstice-oncology","name":"Solstice Oncology","listing_type":"company","profile_url":"/companies/solstice-oncology"},"type_data":{"product_kind":"other"},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Health"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-10T08:21:25.406Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-10T08:21:25.406Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"health","name":"Health","note":null,"profile_url":"/categories/health"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}]}}